We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

117 hedge funds and large institutions have $833M invested in Mirum Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

12,221% more call options, than puts

Call options by funds: $10.3M | Put options by funds: $84K

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

28% more capital invested

Capital invested by funds: $650M → $833M (+$183M)

13% more funds holding

Funds holding: 104 → 117 (+13)

0.95% more ownership

Funds ownership: 90.42% → 91.37% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
117
Holders Change
+13
Holders Change %
+12.5%
% of All Funds
1.86%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
24
Increased
40
Reduced
29
Closed
11
Calls
$10.3M
Puts
$84K
Net Calls
+$10.3M
Net Calls Change
+$9.98M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$18.3M
2
PA
Perceptive Advisors
New York
+$13.7M
3
CCM
Cadian Capital Management
New York
+$8.15M
4
PM
Prosight Management
Texas
+$5.9M
5
SCM
Soleus Capital Management
Connecticut
+$5.52M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$13.4M
2
BlackRock
BlackRock
New York
-$9.73M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$3.41M
4
Citigroup
Citigroup
New York
-$2.24M
5
SCM
Stonepine Capital Management
Oregon
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ensign Peak Advisors
26
Ensign Peak Advisors
Utah
$5.42M – – –
Northern Trust
27
Northern Trust
Illinois
$5.15M +$34.5K +1,512 +0.7%
SAM
28
Silvercrest Asset Management
New York
$4.84M – – –
Wellington Management Group
29
Wellington Management Group
Massachusetts
$3.72M +$2.23K +98 +0.1%
HP
30
Highlander Partners
Texas
$2.95M – – –
SFM
31
Sphera Funds Management
Israel
$2.63M +$2.49M +109,336 New
SCM
32
Silverarc Capital Management
Massachusetts
$2.54M +$2.41M +105,939 New
Bank of America
33
Bank of America
North Carolina
$2.54M -$1.86M -81,518 -44%
LPC
34
Lion Point Capital
New York
$2.33M – – –
SSA
35
Schonfeld Strategic Advisors
New York
$2.29M +$1.04M +45,623 +92%
AAA
36
Affinity Asset Advisors
New York
$2.28M +$1.25M +55,000 +138%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$2.07M -$1.37M -60,083 -41%
N
38
Nuveen
North Carolina
$1.72M -$35.4K -1,554 -2%
SAM
39
Simplify Asset Management
Nevada
$1.68M +$1.6M +70,000 New
Citigroup
40
Citigroup
New York
$1.67M -$2.24M -98,196 -59%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$1.65M +$1.09M +47,900 +230%
IBT
42
International Biotechnology Trust
United Kingdom
$1.62M – – –
PAI
43
Palo Alto Investors
California
$1.55M – – –
Deutsche Bank
44
Deutsche Bank
Germany
$1.52M +$97K +4,256 +7%
PHP
45
Parkman Healthcare Partners
Connecticut
$1.49M +$213K +9,364 +18%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$1.44M -$129K -5,655 -9%
CP
47
CenterBook Partners
Connecticut
$1.31M -$2.53K -111 -0.2%
Charles Schwab
48
Charles Schwab
California
$1.27M +$21.8K +956 +2%
RHJA
49
Rice Hall James & Associates
California
$1.26M +$1.19M +52,295 New
ClearBridge Investments
50
ClearBridge Investments
New York
$1.22M +$451K +19,790 +64%
1
2
3 4 5

MIRM Hedge Fund Activity: Q1 2023 in Review

117 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2023, worth a combined $833M — up 28% from $650M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MIRM positions and 11 closed out — a net gain of 13 holders — while 40 added to existing stakes and 29 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $18.3M. The largest seller was State Street, cutting an estimated $13.4M.

  • 117 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2023, up from 104 in Q4 2022.
  • Funds reported $833M of Mirum Pharmaceuticals stock for Q1 2023, up 28% quarter-over-quarter.
  • 24 funds opened new Mirum Pharmaceuticals positions in Q1 2023 and 11 closed out, a net change of +13 holders.
  • The largest Mirum Pharmaceuticals buyer in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $18.3M added.
  • The largest Mirum Pharmaceuticals seller in Q1 2023 was State Street, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2023.